Plasma therapy for TTP [letter]
نویسندگان
چکیده
منابع مشابه
Treatment of COVID-19 patients using plasma therapy: Letter to Editor
The symptoms of COVID-19, caused by the newly known type of coronavirus, vary widely from asymptomatic, mild to severe respiratory infection leading to hospitalization or death of patients. To date, no specific drug has been reported for the treatment of patients affected by this virus. One of the approaches adopted for the treatment of this disease is the use of plasma therapy, which contains ...
متن کاملCancer-related TTP and considerations of plasma exchange.
The diagnosis and therapy of thrombotic thrombocytopenic purpura (TTP) have advanced dramatically in the past 25 years, with increasing diagnostic awareness spurred on by the discovery of plasma exchange as an effective therapy. Rarely is the pentad of thrombocytopenia, anemia, renal dysfunction, neurologic dysfunction, and fever present before the diagnosis is made, and now any time that throm...
متن کاملEfficacy of Tissue Tolerable Plasma (TTP) against Ixodes ricinus
The efficacy of Tissue Tolerable Plasma (TTP) against ticks was tested, as data from the literature has demonstrated its efficacy against other acari. The study was carried out by using the KINPen09 (Argon as carrier gas) on Ixodes ricinus (n=24). Treatment times of 1 and 3 minutes led to a reversible inactivation of the ticks. After 5 min of treatment, they died. Thanks to the acaricidal effec...
متن کاملTtp Sim : a Versatile Simulation Environment for Ttp/c
Future electronic systems for the implementation of safety-critical applications on-board automotive vehicles will be based on distributed embedded systems. The most critical component in such systems is the communication network that connects the individual electronic modules. For reasons of costs, composability, ease of validation, and certiication the use of time-triggered communication prot...
متن کاملEffects of Anti - FVIII / vWF lgG on the TTP Plasma - Induc ed Platelet Aggregation Plasma
Von Willebrand factor (vWF) has been implicated to function as a cofactor in platelet aggregation induced by thrombotic thrombocytopenic purpura (TTP) plasma. To investigate further this role of vWF, we have used rabbit monospecific anti-FVIII/vWF antibodies and a monoclonal antibody to platelet glycoprotein lb (GP Ib) that blocks the ristocetin-induced platelet aggregation. The monoclonal anti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Blood
سال: 1981
ISSN: 0006-4971,1528-0020
DOI: 10.1182/blood.v58.2.409.bloodjournal582409